Zobrazeno 1 - 10
of 652
pro vyhledávání: '"Hyeoung‐Joon Kim"'
Autor:
Ga-Young Song, Hyeon-Jong Kim, TaeHyung Kim, Seo-Yeon Ahn, Sung-Hoon Jung, Mihee Kim, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, June-Won Cheong, Chul Won Jung, Jun Ho Jang, Hee- Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Seong Kyu Park, Sung-Hyun Kim, Chang Kyun Choi, Hyeoung-Joon Kim, Jae-Sook Ahn, Dennis Dong Hwan Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study aimed to validate the 2022 European LeukemiaNet (ELN) risk stratification for acute myeloid leukemia (AML). A total of 624 newly diagnosed AML patients from 1998 to 2014 were included in the analysis. Genetic profiling was conduct
Externí odkaz:
https://doaj.org/article/3666f09433ea4f3db96d59f70fd89d44
Autor:
Ga-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, Mihee Kim, Jae-Sook Ahn, Je-Jung Lee, Hyeoung-Joon Kim, Jang Bae Moon, Su Woong Yoo, Seong Young Kwon, Jung-Joon Min, Hee-Seung Bom, Sae-Ryung Kang, Deok-Hwan Yang
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 2, Pp 327-337 (2024)
Background/Aims The prognostic significance of 18F-fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET/CT) in peripheral T-cell lymphomas (PTCLs) are controversial. We explored the prognostic impact of sequential 18F-FDG PE
Externí odkaz:
https://doaj.org/article/f68b3f42ad874e70950684a373958588
Autor:
Manh-Cuong Vo, Sung-Hoon Jung, Van-Tan Nguyen, Van-Dinh-Huan Tran, Nodirjon Ruzimurodov, Sang Ki Kim, Xuan-Hung Nguyen, Mihee Kim, Ga-Young Song, Seo-Yeon Ahn, Jae-Sook Ahn, Deok-Hwan Yang, Hyeoung-Joon Kim, Je-Jung Lee
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e27892- (2024)
Despite major advances in therapeutic platforms, most patients with multiple myeloma (MM) eventually relapse and succumb to the disease. Among the novel therapeutic options developed over the past decade, genetically engineered T cells have a great d
Externí odkaz:
https://doaj.org/article/3ec216687cfc4d078c9ef864082f2bab
Autor:
Suhyeon Kim, Jiye Jung, Seo-Yeon Ahn, Mihee Kim, So Yeon Jeon, Chang-Hoon Lee, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Byung-Soo Kim, Hyeoung-Joon Kim, Jae-Yong Kwak, Yong Park, Jae-Sook Ahn, Ho-Young Yhim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionDespite the current effective treatments for acute promyelocytic leukemia (APL), early mortality (EM), defined as death within 30 days of presentation, is a major hurdle to long-term survival.MethodsWe performed a multicenter retrospectiv
Externí odkaz:
https://doaj.org/article/08d6174f21f24c38aeeff570d43c37d0
Autor:
Mihee Kim, TaeHyung Kim, Seo-Yeon Ahn, Jun Hyung Lee, Ju Heon Park, Myung-Geun Shin, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Mi Yeon Kim, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 4, Pp 534-545 (2023)
Background/Aims We evaluated the role of next-generation sequencing (NGS)-based disease monitoring for elderly patients diagnosed with acute myeloid leukemia (AML) who received decitabine therapy. Methods A total of 123 patients aged > 65 years with
Externí odkaz:
https://doaj.org/article/fb0883648f054a2fa3142217bb12b643
Autor:
Ga-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, Mihee Kim, Jae-Sook Ahn, Je-Jung Lee, Hyeoung-Joon Kim, Jang Bae Moon, Su Woong Yoo, Seong Young Kwon, Jung-Joon Min, Hee-Seung Bom, Sae-Ryung Kang, Deok Hwan Yang
Publikováno v:
HemaSphere, Vol 7, p e64743b7 (2023)
Externí odkaz:
https://doaj.org/article/2a6c7ed1f2364b34ac56b0508ca3705b
Autor:
Mihee Kim, Seo-Yeon Ahn, TaeHyung Kim, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Ju Heon Park, Myung-Geun Shin, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTObjectives This study aimed to evaluate the prognostic significance of the revised European LeukemiaNet (ELN)−2022 risk stratification model for 123 elderly acute myeloid leukemia (AML) patients treated with decitabine chemotherapy.Results
Externí odkaz:
https://doaj.org/article/dd0b63ffec98445ba69d2626086a7637
Autor:
Jae‐Sook Ahn, TaeHyung Kim, Sung‐Hoon Jung, Seo‐Yeon Ahn, Ga‐Young Song, Mihee Kim, Deok‐Hwan Yang, Je‐Jung Lee, Mi Yeon Kim, Joon Ho Moon, Zhaolei Zhang, Hyeoung‐Joon Kim, Dennis Dong Hwan Kim
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1145-1153 (2022)
Abstract In this study, we performed serial monitoring using targeted DNA sequencing to identify genetic alterations in adults with Philadelphia‐positive acute lymphoblastic leukemia (Ph‐ALL). Deep sequencing was performed by targeting the coding
Externí odkaz:
https://doaj.org/article/f2da94d9169441dba969903070bcf041
Autor:
Hiroshi Handa, June-Won Cheong, Yasushi Onishi, Hiroatsu Iida, Yukio Kobayashi, Hyeoung-Joon Kim, Tzeon-Jye Chiou, Koji Izutsu, Olga Tsukurov, Xiaofei Zhou, Helene Faessel, Ying Yuan, Farhad Sedarati, Douglas V. Faller, Akiko Kimura, Shang-Ju Wu
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-5 (2022)
Abstract Pevonedistat, the first small-molecule inhibitor of NEDD8-activating enzyme, has demonstrated clinical activity in Western patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). We report findings from a phase 1/1b s
Externí odkaz:
https://doaj.org/article/16e57d9cb04a4e2ea784bdfdd8aa57cf
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-16 (2022)
Abstract Background BCR-ABL-independent drug resistance is a barrier to curative treatment of chronic myeloid leukemia (CML). However, the molecular pathways underlying BCR-ABL-independent tyrosine kinase inhibitor (TKI) resistance remain unclear. Me
Externí odkaz:
https://doaj.org/article/2571c977aceb49f1b5e44a5d2466efd6